Work

O-0022 X-Pect Study Results: A Phase III Randomized Study of Perifosine Plus Capecitabine vs. Placebo Plus Capecitabine in Refractory mCRC Patients

Year: 2012

Type: article

Source: Annals of Oncology

DOI: 10.1016/s0923-7534(19)66486-0

Authors: Johanna Bendell, Thomas Ervin, Neil Senzer, Donald Richards, Irfan Firdaus, A. Craig Lockhart, Allen Cohn, Mansoor Saleh, Peter Sportelli, Lesa Gardner, Cathy Eng

Institutions: Sarah Cannon, Mary Crowley Cancer Research Center, Texas Oncology, Oncology Hematology Care, Washington University in St. Louis, Rocky Mountain Cancer Centers, Georgia Cancer Specialists, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3000367520

FWCI:

Cites:

Cited by:

Related to: 10